European Journal of Surgical Oncology
Volume 33, Issue 4 , Pages 424-429 , May 2007

Variations in treatment of ductal carcinoma in situ of the breast: A population-based study in the East Netherlands

  • A.P. Schouten van der Velden

      Affiliations

    • Department of Surgical Oncology, Radboud University Nijmegen Medical Centre, The Netherlands
    • ,
  • J.A.A.M. Van Dijck

      Affiliations

    • Comprehensive Cancer Centre East Netherlands (IKO), Nijmegen, The Netherlands
    • Department of Epidemiology and Biostatistics, Radboud University Nijmegen Medical Centre, The Netherlands
    • ,
  • Th. Wobbes

      Affiliations

    • Department of Surgical Oncology, Radboud University Nijmegen Medical Centre, The Netherlands
    • Corresponding Author InformationCorresponding author. Department of Surgical Oncology, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands. Tel.: +31 24 3616421; fax: +31 24 3540501.

,Accepted 21 September 2006.

References 

  1. Burnstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM. Ductal carcinoma in situ of the breast. New Engl J Med. 2004;350:1430–1441
  2. Welch HG, Black WC. Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast disease can we find?. Ann Intern Med. 1997;127:1023–1028
  3. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C. Incidence of and treatment for ductal carcinoma of the breast. JAMA. 1996;275:913–918
  4. Ernster VL, Ballard-Brabash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94:1546–1554
  5. Fracheboud J, Otto SJ, Van Dijck JAAM. Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer. 2004;91:861–867
  6. Gupta SK, Douglas-Jones AG, Fenn N, Morgan JM, Mansel RE. The clinical behaviour of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ). Cancer. 1997;80:1740–1745
  7. Farabegoli F, Champene M-H, Bieche I, et al. Genetic pathways in the evolution of breast carcinoma in situ. J Pathol. 2002;196:280–286
  8. Ernster V, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med. 2000;160:953–958
  9. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomised trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241
  10. Schwartz GF, Solin LJ, Olivotto IA, Ernster VL, Pressman PI. Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22–25, 1999. Cancer. 2000;15:946–954
  11. Baxter NN, Virnig BA, Durham SB, Tuttle TM. Trends in treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2004;96:443–448
  12. Ottesen GL, Graversen HP, Blichert-Toft M, Christensen IJ, Andersen JA. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Breast Cancer Res Treat. 2000;62:197–210
  13. Page DL, Dupont WD, Rogers WL, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15–25 years after diagnosis of low grade ductal carcinoma in situ of the breast treated only with biopsy. Cancer. 1995;76:1197–1200
  14. Solin LJ, Fourquet A, Vicini FA, et al. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast. Cancer. 2001;91:1090–1097
  15. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med. 1993;328:1581–1586
  16. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and bowel project B-17. J Clin Oncol. 1998;16:441–452
  17. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the national surgical adjuvant breast project (NSABP) eight year update of protocol B-17. Cancer. 1999;86:429–438
  18. Julien J-P, Bijker N, Fentiman IS, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. Lancet. 2000;355:528–533
  19. UK Coordinating Committee on Cancer Research DCIS Working Party . Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: a randomised controlled trial. Lancet. 2003;362:95–102
  20. Choi WS, Parker BA, Pierce JP, Greenberg ER. Regional differences in the incidence and treatment of carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 1996;5:317–320
  21. Winchester DJ, Menck HR, Winchester DP. National treatment trends for ductal carcinoma in situ of the breast. Arch Surg. 1997;132:660–665
  22. Verkooijen HM, Fioretta G, de Wolf C, et al. Management of women with ductal carcinoma in situ of the breast: a population-based study. Ann Oncol. 2002;13:1236–1245
  23. Ceilley E, Jagsi R, Goldberg S, Kachnic L, Powell S, Taghian A. The management of ductal carcinoma in situ in North America and Europe. Cancer. 2004;101:1958–1967
  24. Kricker A, Armstrong B. Surgery and outcomes of ductal carcinoma in situ of the breast: a population-based study in Australia. Eur J Cancer. 2004;40:2396–2402
  25. Silverstein MJ. Not everyone with ductal carcinoma in situ of the breast treated with breast preservation needs post-excisional radiation therapy. Breast. 2000;9:189–193
  26. Silverstein MJ, Lagios MD, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer. 1996;77:2267–2274
  27. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 1999;340:1455–1461
  28. Silverstein MJ. The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg. 2003;186:337–343
  29. Lagios MD, Silverstein MJ. Sentinel node biopsy for patients with DCIS: a dangerous and unwarranted direction. Ann Surg Oncol. 2001;8:275–277
  30. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ. Relationship of extent of non-invasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer. 1982;50:1309–1314
  31. Zelis JJ, Sickle-Santanello BJ, Liang WC, Nims TA. Do not contemplate invasive surgery for ductal carcinoma in situ. Am J Surg. 2002;184:348–349
  32. Intra M, Veronesi P, Mazzarol G, et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg. 2003;138:209–213
  33. Lara JF, Young SM, Velilla RE, Santoro EJ, Templeton SF. The relevance of occult axillary micrometastasis in ductal carcinoma in situ. Cancer. 2003;98:2105–2113

PII: S0748-7983(06)00346-5

doi: 10.1016/j.ejso.2006.09.018

European Journal of Surgical Oncology
Volume 33, Issue 4 , Pages 424-429 , May 2007

Article Tools

* Image Usage & Resolution